<DOC>
	<DOC>NCT01592552</DOC>
	<brief_summary>The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.</brief_summary>
	<brief_title>A Biospecimen and Clinical Data Study on Patients With Alzheimer's, Multiple Sclerosis, Parkinson's, and Huntington's, for Drug &amp; Biomarker Discovery</brief_title>
	<detailed_description>Blood samples are collected in the comfort and safety of your home by a certified medical professional. We have mobile phlebotomists located in major metropolitan areas around the nation for your convenience.</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Huntington Disease</mesh_term>
	<criteria>Males and females &gt;18 to 100 years old A diagnosis of neurological condition Proof of diagnosis can be provided Control group: Healthy donors, males and females, 18 to 100 years of age Exclusion Criteria Receipt of blood products within 30 days of study enrollment Receipt of an investigational (unapproved) drug within 30 days of study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Alzheimer's Disease</keyword>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Parkinson's Disease</keyword>
	<keyword>Huntington's Disease</keyword>
	<keyword>Amyotrophic Lateral Sclerosis (ALS)</keyword>
</DOC>